297 related articles for article (PubMed ID: 6172356)
1. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
Marks WH; Eddeland A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
[TBL] [Abstract][Full Text] [Related]
2. The elimination in dogs of trypsin-alpha-macroglobulin complexes inactivated by the Kazal or the Kunitz inhibitor.
Eddeland A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1978 Mar; 359(3):379-84. PubMed ID: 76602
[TBL] [Abstract][Full Text] [Related]
3. On the role of the pancreatic secretory trypsin inhibitor as an inactivator of trypsin-alpha 2-macroglobulin complexes in acute pancreatitis.
Balldin G; Borgström A; Marks WH; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1984 Jul; 365(7):751-6. PubMed ID: 6207093
[TBL] [Abstract][Full Text] [Related]
4. Studies on the pancreatic secretory trypsin inhibitor in plasma and its complex with trypsin in vivo and in vitro.
Eddeland A; Ohlsson K
Scand J Clin Lab Invest; 1978 Oct; 38(6):507-15. PubMed ID: 81511
[TBL] [Abstract][Full Text] [Related]
5. Trasylol prevents trypsin-induced shock in dogs.
Balldin G; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1979 May; 360(5):651-6. PubMed ID: 89067
[TBL] [Abstract][Full Text] [Related]
6. Partition of trypsin and Kazal inhibitor in reaction mixtures with human serum.
Eddeland A
Hoppe Seylers Z Physiol Chem; 1979 Feb; 360(2):145-9. PubMed ID: 422124
[TBL] [Abstract][Full Text] [Related]
7. [Antitrypsin effects of alpha-2-macroglobulin].
Serkhan V; Shcherbak IG
Vopr Med Khim; 1990; 36(6):47-50. PubMed ID: 1706121
[TBL] [Abstract][Full Text] [Related]
8. Studies on the influence of Trasylol on the partition of trypsin between the human plasma protease inhibitors in vitro.
Balldin G; Ohlsson K; Olsson AS
Hoppe Seylers Z Physiol Chem; 1978 Jun; 359(6):691-7. PubMed ID: 307526
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay for human pancreatic secretory trypsin inhibitor: measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic diseases.
Kitahara T; Takatsuka Y; Fujimoto KI; Tanaka S; Ogawa M; Kosaki G
Clin Chim Acta; 1980 Apr; 103(2):135-43. PubMed ID: 6154549
[TBL] [Abstract][Full Text] [Related]
10. Purification, characterization and amino-acid sequencing of two pancreatic secretory trypsin inhibitors in rat pancreatic juice.
Uda K; Ogawa M; Shibata T; Murata A; Mori T; Kikuchi N; Yoshida N; Tsunasawa S; Sakiyama F
Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():55-61. PubMed ID: 3202973
[TBL] [Abstract][Full Text] [Related]
11. Differences in stimulatory effects between rat pancreatic secretory trypsin inhibitor-61 and -56 on rat pancreas.
Miyasaka K; Funakoshi A; Nakamura R; Kitani K; Uda K; Murata A; Ogawa M
Jpn J Physiol; 1989; 39(6):891-9. PubMed ID: 2632901
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of peptide hormones by alpha 2-macroglobulin-trypsin complex and its relation to the pathogenesis and chemotherapy of acute pancreatitis.
Hermon-Taylor J; Magee AI; Grant DA; Jones PA; Marshall CE; Dunham J
Clin Chim Acta; 1981 Jan; 109(2):203-9. PubMed ID: 6162593
[TBL] [Abstract][Full Text] [Related]
13. Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A.
Tsuzuki S; Kokado Y; Satomi S; Yamasaki Y; Hirayasu H; Iwanaga T; Fushiki T
Biochem J; 2003 May; 372(Pt 1):227-33. PubMed ID: 12590650
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of DNA synthesis in human fibroblasts by human pancreatic secretory trypsin inhibitor.
Ogawa M; Tsushima T; Ohba Y; Ogawa N; Tanaka S; Ishida M; Mori T
Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):155-8. PubMed ID: 3909270
[TBL] [Abstract][Full Text] [Related]
15. Purification of canine pancreatic secretory trypsin inhibitor and interaction in vitro with complexes of trypsin-alpha-macroglobulin.
Eddeland A; Ohlsson K
Scand J Clin Lab Invest; 1976 Dec; 36(8):815-20. PubMed ID: 73214
[TBL] [Abstract][Full Text] [Related]
16. Elevation of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with serious injury.
Ogawa M; Matsuda K; Shibata T; Matsuda Y; Ukai T; Ohta M; Mori T
Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):259-66. PubMed ID: 2417295
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
Berling R; Borgström A; Ohlsson K
Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
[TBL] [Abstract][Full Text] [Related]
18. Influence of plasma protease inhibitors and Trasylol on trypsin-induced bradykinin-release in vitro and in vivo. Protease inhibitors and trypsin-induced bradykinin release.
Balldin G; Gustafsson EL; Ohlsson K
Eur Surg Res; 1980; 12(4):260-9. PubMed ID: 6166477
[TBL] [Abstract][Full Text] [Related]
19. The bifunctional rat pancreatic secretory trypsin inhibitor/monitor peptide provides protection against premature activation of pancreatic juice.
Graf R; Klauser S; Fukuoka SI; Schiesser M; Bimmler D
Pancreatology; 2003; 3(3):195-206. PubMed ID: 12771515
[TBL] [Abstract][Full Text] [Related]
20. Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man.
Lasson A; Dittmann B; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1315-22. PubMed ID: 6195066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
